Fig. 2From: Significance of mesothelin and CA125 expression in endometrial carcinoma: a retrospective analysisProgression-free survival (PFS) and overall survival (OS) of patients according to their differences in expression of mesothelin and CA125, and in the co-expression of both mesothelin and CA125. PFS (a) and OS (b) according to mesothelin expression, PFS (c) and OS (d) according to CA125 expression, and PFS (e) and OS (f) co-expression of both were shownBack to article page